Avinger to Present at LD Micro Investor Conference

Rhea-AI Summary

Avinger (NASDAQ:AVGR), a medical device company, will have CEO Jeff Soinski at the LD Micro Main Event XV on October 25, 2022, at 10:00 a.m. PT. The event, held at the Luxe Sunset Boulevard Hotel in Los Angeles, will feature live streaming available at this link. Avinger is focused on innovative solutions for Peripheral Artery Disease (PAD), affecting millions worldwide. They invite investors to schedule meetings during the conference through their investor relations.

REDWOOD CITY, CA / ACCESSWIRE / October 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced that Chief Executive Officer Jeff Soinski will participate in the following investor conference event during October 2022.

Event:		LD Micro Main Event XV
Date:		Tuesday, October 25, 2022
Presentation:		10:00 a.m. Pacific Time
Live stream:		https://me22.mysequire.com/
Location:		Luxe Sunset Boulevard Hotel, Los Angeles

Management will host individual investor meetings during the conference. To arrange a meeting with Avinger, please contact your conference representative. Investors attending the conference may also contact Avinger investor relations at mkreps@darrowir.com to arrange an in-person meeting.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox series of imaging consoles, the Ocelot and Tigereye™ family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on Twitter and Facebook.

Investor Contact:

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.

View source version on accesswire.com:
https://www.accesswire.com/720889/Avinger-to-Present-at-LD-Micro-Investor-Conference

FAQ

What is the date of Avinger's presentation at the LD Micro Main Event XV?

Avinger's presentation is scheduled for October 25, 2022.

What time will Avinger present at the LD Micro Main Event XV?

Avinger's presentation will take place at 10:00 a.m. Pacific Time.

Where is the LD Micro Main Event XV being held?

The event is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

How can investors schedule a meeting with Avinger during the conference?

Investors can arrange a meeting by contacting their conference representative or Avinger investor relations.

What is the focus of Avinger's medical technology?

Avinger focuses on image-guided, catheter-based systems for diagnosing and treating Peripheral Artery Disease.